LANDOS BIOPHARMA INC (LABP)

US5150692011 - Common Stock

22.33  -0.03 (-0.13%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
37.50M36.64M8.31M2.42M9.81M
Marketable Securities
0.007.76M82.58M25.72M40.16M
Receivables
N/AN/AN/A150.00K0.00
Other Current Assets
541.00K850.00K1.27M1.60M140.00K
Total Current Assets
38.04M45.25M92.15M29.89M50.11M
 
Non-Current Assets
PPE Net
N/A0.00710.00K440.00K360.00K
Other Non-Current Assets
N/A0.0030.00K0.0010.00K
Total Non-Current Assets
0.000.00730.00K440.00K370.00K
 
TOTAL ASSETS
38.04M45.25M92.88M30.33M50.48M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
4.87M2.69M3.70M1.94M980.00K
Accounts Payable
1.38M3.44M12.91M8.61M2.05M
Other Current Liabilities
N/AN/A0.00490.00KN/A
Total Current Liabilities
6.25M6.12M16.61M11.03M3.03M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
N/AN/A0.00280.00KN/A
Total Non-Current Liabilities
0.000.000.00280.00K0.00
 
TOTAL LIABILITIES
6.25M6.12M16.61M11.31M3.03M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-155.36M-133.43M-94.15M-55.73M-25.59M
Additional Paid In Capital
187.12M172.21M170.24M1.63M20.00K
Common Shares
31.00K400.00K400.00K73.11M73.10M
Other Shareholders' Equity
0.00-60.00K-230.00K10.00K-80.00K
Shares Outstanding
3.12M4.03M4.03M4.01M3.92M
Tangible Book Value per Share
10.209.7118.93-13.47-6.53
Total Shareholders' Equity
31.79M39.13M76.27M19.02M47.45M
 
TOTAL LIABILITIES AND EQUITY
38.04M45.25M92.88M30.33M50.48M
 
Statistics
Current Ratio
6.097.395.552.7116.54
Return On Assets (ROA)
-57.66%-86.81%-41.37%-99.37%-26.68%
Return On Equity (ROE)
-69.00%-100.38%-50.37%-158.46%-28.39%

All data in USD

Charts